A U.S. Court has dismissed a lawsuit filed by HDT Bio Corp against Pune-based Emcure Pharmaceuticals.
A Federal court in Seattle, Washington, has dismissed the lawsuit filed by HDT against Emcure regarding Covid-19 vaccine technology.
HDT had named Emcure as a party in the suit, alleging non-payment of royalties and demanded a compensation of at least $950 million.
When contacted a company spokesperson said, "The ruling vindicates our stand".
ADVERTISEMENT
Emcure had contended in the court that the lawsuit was illegitimate and brought by HDT to compensate for its business shortcomings.
HDT Bio had alleged that the Pune-based firm had stolen its vaccine technology which it had licensed to Gennova for manufacture and distribution in India.
Add us to your Preferences
Set as your preferred source on Google
ADVERTISEMENT
RECOMMENDED FOR YOU

Trump Considering Lawsuit Against Powell: White House


Supreme Court Rules Out Coercive Action Against Owners Of Old Vehicles In NCR


'All Leftover Food Items Must Be...': SC's Directive For Court Premises After Stray-Dog Order


Jon Prosser Drops New Video On iPhone 17 Pro Renders Despite Apple Lawsuit Over iOS 26 Leaks
